Amgen (AMGN) |
United States |
$138.902B |
16.00 |
CSL (CSLLY) |
Australia |
$87.394B |
0.00 |
Gilead Sciences (GILD) |
United States |
$84.866B |
10.51 |
Vertex Pharmaceuticals (VRTX) |
United States |
$57.409B |
58.60 |
Biogen (BIIB) |
United States |
$54.179B |
9.30 |
Illumina (ILMN) |
United States |
$47.991B |
52.66 |
Regeneron Pharmaceuticals (REGN) |
United States |
$40.872B |
17.90 |
Alexion Pharmaceuticals (ALXN) |
United States |
$25.203B |
12.45 |
Incyte (INCY) |
United States |
$20.351B |
47.24 |
Seattle Genetics (SGEN) |
United States |
$20.138B |
0.00 |
SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$17.624B |
0.00 |
Genmab (GNMSF) |
Denmark |
$14.761B |
65.20 |
BioMarin Pharmaceutical (BMRN) |
United States |
$14.356B |
0.00 |
Alnylam Pharmaceuticals (ALNY) |
United States |
$13.798B |
0.00 |
Galapagos (GLPG) |
Belgium |
$11.704B |
30.16 |
Exact Sciences (EXAS) |
United States |
$11.197B |
0.00 |
Bio-Rad Laboratories (BIO.B) |
United States |
$10.393B |
49.88 |
QIAGEN (QGEN) |
Netherlands |
$9.429B |
30.74 |
BeiGene (BGNE) |
Cayman Islands |
$8.976B |
0.00 |
Bio-Techne Corp (TECH) |
United States |
$8.358B |
55.95 |
Sarepta Therapeutics (SRPT) |
United States |
$8.159B |
0.00 |
Amarin (AMRN) |
Ireland |
$8.019B |
0.00 |
ACADIA Pharmaceuticals (ACAD) |
United States |
$7.917B |
0.00 |
Guardant Health (GH) |
United States |
$6.947B |
0.00 |
Medicines (MDCO) |
United States |
$6.714B |
0.00 |
Moderna (MRNA) |
United States |
$6.312B |
0.00 |
Horizon Therapeutics Public (HZNP) |
Ireland |
$6.037B |
15.35 |
Reata Pharmaceuticals (RETA) |
United States |
$6.034B |
0.00 |
ARGENX SE-ADR (ARGX) |
Netherlands |
$5.618B |
0.00 |
BioNTech SE (BNTX) |
Germany |
$5.514B |
0.00 |
Exelixis (EXEL) |
United States |
$5.275B |
14.84 |
Repligen (RGEN) |
United States |
$4.701B |
85.19 |
China Biologic Products (CBPO) |
China |
$4.603B |
25.93 |
Ascendis Pharma (ASND) |
Denmark |
$4.532B |
0.00 |
Bluebird Bio (BLUE) |
United States |
$4.394B |
0.00 |
Spark Therapeutics (ONCE) |
United States |
$4.263B |
0.00 |
MorphoSys AG (MOR) |
Germany |
$4.153B |
0.00 |
Mirati Therapeutics (MRTX) |
United States |
$4.047B |
0.00 |
CRISPR Therapeutics AG (CRSP) |
Switzerland |
$3.995B |
0.00 |
Immunomedics (IMMU) |
United States |
$3.981B |
0.00 |
Blueprint Medicines (BPMC) |
United States |
$3.861B |
0.00 |
Adaptive Biotechnologies (ADPT) |
United States |
$3.613B |
0.00 |
Intercept Pharmaceuticals (ICPT) |
United States |
$3.518B |
0.00 |
Alkermes (ALKS) |
Ireland |
$3.300B |
0.00 |
MyoKardia (MYOK) |
United States |
$3.117B |
0.00 |
Genmab (GMAB) |
Denmark |
$3.064B |
6.31 |
UniQure (QURE) |
Netherlands |
$2.881B |
0.00 |
Emergent Biosolutions (EBS) |
United States |
$2.838B |
28.19 |
Halozyme Therapeutics (HALO) |
United States |
$2.808B |
0.00 |
NeoGenomics (NEO) |
United States |
$2.779B |
147.89 |
Acceleron Pharma (XLRN) |
United States |
$2.648B |
0.00 |
Amicus Therapeutics (FOLD) |
United States |
$2.576B |
0.00 |
Ultragenyx Pharmaceutical (RARE) |
United States |
$2.484B |
0.00 |
Arena Pharmaceuticals (ARNA) |
United States |
$2.408B |
5.60 |
Zai Lab (ZLAB) |
China |
$2.399B |
0.00 |
RA PHARMCTL INC (RARX) |
United States |
$2.216B |
0.00 |
Insmed (INSM) |
United States |
$2.064B |
0.00 |
Myriad Genetics (MYGN) |
United States |
$1.905B |
28.14 |
Ligand Pharmaceuticals (LGND) |
United States |
$1.897B |
36.49 |
Dicerna Pharmaceuticals (DRNA) |
United States |
$1.822B |
0.00 |
Momenta Pharmaceuticals (MNTA) |
United States |
$1.782B |
0.00 |
Denali Therapeutics (DNLI) |
United States |
$1.754B |
0.00 |
Epizyme (EPZM) |
United States |
$1.659B |
0.00 |
Akcea Therapeutics (AKCA) |
United States |
$1.656B |
0.00 |
Zymeworks (ZYME) |
Canada |
$1.648B |
0.00 |
REGENXBIO (RGNX) |
United States |
$1.647B |
0.00 |
Editas Medicine (EDIT) |
United States |
$1.586B |
0.00 |
Nabriva Therapeutics AG (NBRV) |
Ireland |
$1.402B |
0.00 |
Athenex (ATNX) |
United States |
$1.376B |
0.00 |
Alector (ALEC) |
United States |
$1.362B |
0.00 |
Sangamo Therapeutics (SGMO) |
United States |
$1.352B |
0.00 |
Innoviva (INVA) |
United States |
$1.308B |
3.85 |
Arvinas (ARVN) |
United States |
$1.297B |
0.00 |
Coherus BioSciences (CHRS) |
United States |
$1.273B |
0.00 |
Principia Biopharma (PRNB) |
United States |
$1.226B |
0.00 |
Orchard Therapeutics (ORTX) |
United Kingdom |
$1.151B |
0.00 |
Zealand Pharma (ZLDPF) |
Denmark |
$1.129B |
0.00 |
WAVE Life Sciences (WVE) |
Singapore |
$1.109B |
0.00 |
Zealand Pharma (ZEAL) |
Denmark |
$1.046B |
0.00 |
Fate Therapeutics (FATE) |
United States |
$1.033B |
0.00 |
Precision BioSciences (DTIL) |
United States |
$0.998B |
0.00 |
Pharming Group (PHGUF) |
Netherlands |
$0.968B |
0.00 |
ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.934B |
0.00 |
Vanda Pharmaceuticals (VNDA) |
United States |
$0.932B |
7.83 |
Codexis (CDXS) |
United States |
$0.909B |
0.00 |
Achillion Pharmaceuticals (ACHN) |
United States |
$0.864B |
0.00 |
BAVARIAN NORDIC (BVNRY) |
Denmark |
$0.846B |
0.00 |
Intellia Therapeutics (NTLA) |
United States |
$0.836B |
0.00 |
Vericel (VCEL) |
United States |
$0.833B |
310.50 |
MiMedx (MDXG) |
United States |
$0.821B |
0.00 |
Anika Therapeutics (ANIK) |
United States |
$0.820B |
26.61 |
Twist Bioscience (TWST) |
United States |
$0.813B |
0.00 |
Heska (HSKA) |
United States |
$0.749B |
191.46 |
Adverum Biotechnologies (ADVM) |
United States |
$0.738B |
0.00 |
Revance Therapeutics (RVNC) |
United States |
$0.736B |
0.00 |
ANI Pharmaceuticals (ANIP) |
United States |
$0.718B |
12.25 |
DBV Technologies S.A (DBVT) |
France |
$0.717B |
0.00 |
UROGEN PHARMA (URGN) |
United States |
$0.685B |
0.00 |
Cara Therapeutics (CARA) |
United States |
$0.671B |
0.00 |
Mesoblast (MESO) |
Australia |
$0.665B |
0.00 |
Cellectis S.A (CLLS) |
France |
$0.623B |
0.00 |
GENFIT S.A (GNFT) |
France |
$0.596B |
0.00 |
AC Immune SA (ACIU) |
Switzerland |
$0.593B |
13.72 |
Autolus Therapeutics (AUTL) |
United Kingdom |
$0.592B |
0.00 |
Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.590B |
0.00 |
Kadmon Holdings (KDMN) |
United States |
$0.584B |
0.00 |
Sorrento Therapeutics (SRNE) |
United States |
$0.579B |
0.00 |
BioDelivery Sciences (BDSI) |
United States |
$0.576B |
0.00 |
PHARMA MAR SA (PHMMF) |
Spain |
$0.570B |
0.00 |
Retrophin (RTRX) |
United States |
$0.570B |
0.00 |
Intra-Cellular Therapies (ITCI) |
United States |
$0.564B |
0.00 |
Cytokineticsorporated (CYTK) |
United States |
$0.557B |
0.00 |
Agenus (AGEN) |
United States |
$0.537B |
0.00 |
Clovis Oncology (CLVS) |
United States |
$0.527B |
0.00 |
Lexicon Pharmaceuticals (LXRX) |
United States |
$0.518B |
3.58 |
Stemline Therapeutics (STML) |
United States |
$0.517B |
0.00 |
OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$0.514B |
0.00 |
Prothena (PRTA) |
Ireland |
$0.513B |
0.00 |
Dynavax Technologies (DVAX) |
United States |
$0.478B |
0.00 |
Bellus Health (BLU) |
Canada |
$0.402B |
0.00 |
Merus (MRUS) |
Netherlands |
$0.381B |
0.00 |
AnaptysBio (ANAB) |
United States |
$0.380B |
0.00 |
Arcus Biosciences (RCUS) |
United States |
$0.377B |
0.00 |
AMAG Pharmaceuticals (AMAG) |
United States |
$0.375B |
0.00 |
Xenon Pharmaceuticals (XENE) |
Canada |
$0.361B |
0.00 |
Cellular Biomedicine (CBMG) |
United States |
$0.337B |
0.00 |
PDL BioPharma (PDLI) |
United States |
$0.337B |
8.43 |
OSMOTICA PHARM (OSMT) |
United States |
$0.335B |
0.00 |
Avid Bioservices (CDMO) |
United States |
$0.326B |
0.00 |
Gritstone Oncology (GRTS) |
United States |
$0.325B |
0.00 |
Starpharma Holdings (SPHRY) |
Australia |
$0.320B |
0.00 |
Puma Biotechnology (PBYI) |
United States |
$0.307B |
0.00 |
Kindred Biosciences (KIN) |
United States |
$0.303B |
0.00 |
Geron (GERN) |
United States |
$0.302B |
0.00 |
Kamada (KMDA) |
Israel |
$0.297B |
8.67 |
CytomX Therapeutics (CTMX) |
United States |
$0.286B |
0.00 |
Compugen (CGEN) |
Israel |
$0.276B |
0.00 |
Cue Biopharma (CUE) |
United States |
$0.269B |
0.00 |
Albireo Pharma (ALBO) |
United States |
$0.264B |
0.00 |
Seres Therapeutics (MCRB) |
United States |
$0.257B |
0.00 |
ADMA Biologics Inc (ADMA) |
United States |
$0.256B |
0.00 |
Scholar Rock Holding (SRRK) |
United States |
$0.252B |
0.00 |
MannKind (MNKD) |
United States |
$0.250B |
0.00 |
Inovio Pharmaceuticals (INO) |
United States |
$0.239B |
0.00 |
Syndax Pharmaceuticals (SNDX) |
United States |
$0.236B |
0.00 |
Sutro Biopharma (STRO) |
United States |
$0.233B |
0.00 |
Aeglea BioTherapeutics (AGLE) |
United States |
$0.228B |
0.00 |
Spero Therapeutics (SPRO) |
United States |
$0.228B |
0.00 |
ChromaDex (CDXC) |
United States |
$0.228B |
0.00 |
Biofrontera AG (BFRA) |
Germany |
$0.226B |
0.00 |
XOMA (XOMA) |
United States |
$0.223B |
0.00 |
Theratechnologies (THTX) |
Canada |
$0.221B |
0.00 |
Exicure (XCUR) |
United States |
$0.220B |
0.00 |
Protagonist Therapeutics (PTGX) |
United States |
$0.209B |
0.00 |
Athersys (ATHX) |
United States |
$0.208B |
0.00 |
Senesco Technologies (ELOX) |
United States |
$0.205B |
0.00 |
Mersana Therapeutics (MRSN) |
United States |
$0.203B |
0.00 |
POXEL SA FRANCE (PXXLF) |
France |
$0.203B |
0.00 |
Syros Pharmaceuticals (SYRS) |
United States |
$0.195B |
0.00 |
Pieris Pharmaceuticals (PIRS) |
United States |
$0.188B |
0.00 |
IVERIC Bio (ISEE) |
United States |
$0.183B |
0.00 |
Proteostasis Therapeutics (PTI) |
United States |
$0.182B |
0.00 |
Cerecor (CERC) |
United States |
$0.176B |
0.00 |
Affimed (AFMD) |
Germany |
$0.174B |
0.00 |
Dyadic (DYAI) |
United States |
$0.165B |
0.00 |
Alcobra (ARCT) |
United States |
$0.162B |
0.00 |
EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.162B |
0.00 |
ARAVIVE, INC (ARAV) |
United States |
$0.157B |
0.00 |
Aquinox Pharmaceuticals (NLTX) |
United States |
$0.156B |
0.00 |
NantKwest (NK) |
United States |
$0.155B |
0.00 |
VBI Vaccines (VBIV) |
United States |
$0.154B |
0.00 |
Abeona Therapeutics (ABEO) |
United States |
$0.153B |
0.00 |
Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.149B |
0.00 |
Five Prime Therapeutics (FPRX) |
United States |
$0.142B |
0.00 |
Fortress Biotech (FBIO) |
United States |
$0.141B |
0.00 |
Aptinyx (APTX) |
United States |
$0.139B |
0.00 |
TELA Bio (TELA) |
United States |
$0.136B |
0.00 |
Newron Pharmaceuticals SpA (NWPHF) |
Italy |
$0.134B |
0.00 |
Arsanis (XFOR) |
United States |
$0.133B |
0.00 |
Northwest Biotherapeutics (NWBO) |
United States |
$0.132B |
0.00 |
Nymox Pharmaceutical (NYMX) |
Canada |
$0.132B |
0.00 |
Prometic Life Sciences (LMNL) |
Canada |
$0.131B |
0.00 |
Arbutus Biopharma (ABUS) |
Canada |
$0.130B |
0.00 |
Enzo Biochem (ENZ) |
United States |
$0.130B |
0.00 |
Windtree Therapeutics (WINT) |
United States |
$0.129B |
0.00 |
Celyad SA (CYAD) |
Belgium |
$0.125B |
0.00 |
SESEN BIO, INC (SESN) |
United States |
$0.124B |
0.00 |
Nicox SA (NICXF) |
France |
$0.122B |
0.00 |
AVEO Pharmaceuticals (AVEO) |
United States |
$0.121B |
0.00 |
Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.117B |
0.00 |
Novavax (NVAX) |
United States |
$0.116B |
0.00 |
Menlo Therapeutics (MNLO) |
United States |
$0.104B |
0.00 |
Paratek Pharmaceuticals (PRTK) |
United States |
$0.102B |
0.00 |
Verastem (VSTM) |
United States |
$0.098B |
0.00 |
Strongbridge Biopharma (SBBP) |
United States |
$0.098B |
2.62 |
PHASEBIO PHARMA (PHAS) |
United States |
$0.096B |
0.00 |
Aduro Biotech (ADRO) |
United States |
$0.093B |
0.00 |
Antibe Therapeutics (ATBPF) |
Canada |
$0.093B |
0.00 |
Emmaus Life Sciences (EMMA) |
United States |
$0.092B |
0.00 |
Adocia (ADOCY) |
France |
$0.086B |
0.00 |
OvaScience (MLND) |
United States |
$0.084B |
0.00 |
Acorda Therapeutics (ACOR) |
United States |
$0.082B |
0.00 |
VTv Therapeutics (VTVT) |
United States |
$0.081B |
0.00 |
Liquidia Technologies (LQDA) |
United States |
$0.076B |
0.00 |
ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.076B |
0.00 |
ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.076B |
0.00 |
Synlogic (SYBX) |
United States |
$0.075B |
0.00 |
Selecta Biosciences (SELB) |
United States |
$0.073B |
0.00 |
Vaccinex (VCNX) |
United States |
$0.071B |
0.00 |
Catabasis Pharmaceuticals (CATB) |
United States |
$0.068B |
0.00 |
Clearside Biomedical (CLSD) |
United States |
$0.067B |
0.00 |
Trevena (TRVN) |
United States |
$0.065B |
0.00 |
Prima BioMed (IMMP) |
Australia |
$0.064B |
0.00 |
Organovo Holdings (ONVO) |
United States |
$0.064B |
0.00 |
Catalyst Biosciences (CBIO) |
United States |
$0.063B |
0.00 |
Pluristem Therapeutics (PSTI) |
Israel |
$0.060B |
0.00 |
Spring Bank Pharmaceuticals (SBPH) |
United States |
$0.057B |
0.00 |
Merrimack Pharmaceuticals (MACK) |
United States |
$0.057B |
0.00 |
NewLink Genetics (NLNK) |
United States |
$0.057B |
0.00 |
Applied Genetic Technologies (AGTC) |
United States |
$0.052B |
0.00 |
Idera Pharmaceuticals (IDRA) |
United States |
$0.052B |
0.00 |
Curis (CRIS) |
United States |
$0.052B |
0.00 |
Checkpoint Therapeutics (CKPT) |
United States |
$0.048B |
0.00 |
AquaBounty Technologies (AQB) |
United States |
$0.048B |
0.00 |
Aridis Pharmaceuticals (ARDS) |
United States |
$0.045B |
0.00 |
Vascular Biogenics (VBLT) |
Israel |
$0.044B |
0.00 |
AIT Therapeutics (XAIR) |
United States |
$0.044B |
0.00 |
Orgenesis (ORGS) |
United States |
$0.044B |
2.83 |
Celldex Therapeutics (CLDX) |
United States |
$0.041B |
0.00 |
Alimera Sciences (ALIM) |
United States |
$0.037B |
0.00 |
Sunesis Pharmaceuticals (SNSS) |
United States |
$0.036B |
0.00 |
Stellar Biotechnologies (EDSA) |
Canada |
$0.035B |
0.00 |
DiaMedica Therapeutics (DMAC) |
United States |
$0.034B |
0.00 |
Evogene (EVGN) |
Israel |
$0.033B |
0.00 |
Celsion (CLSN) |
United States |
$0.033B |
0.00 |
Oncobiologics (OTLK) |
United States |
$0.031B |
0.00 |
Bionano Genomics (BNGO) |
United States |
$0.030B |
0.00 |
VIVUS (VVUS) |
United States |
$0.029B |
0.00 |
Fibrocell Science Inc (FCSC) |
United States |
$0.029B |
16.61 |
Apricus Biosciences (SEEL) |
United States |
$0.029B |
0.00 |
Aptevo Therapeutics (APVO) |
United States |
$0.027B |
0.00 |
Caladrius Biosciences (CLBS) |
United States |
$0.027B |
0.00 |
BioCardia (BCDA) |
United States |
$0.027B |
0.00 |
INNOVATE BIOPHARMACEUTICALS, INC (INNT) |
United States |
$0.026B |
0.00 |
Novogen (KZIA) |
Australia |
$0.026B |
0.00 |
Entera Bio (ENTX) |
Israel |
$0.026B |
0.00 |
Soligenix (SNGX) |
United States |
$0.024B |
0.00 |
Aerpio Pharmaceuticals (ARPO) |
United States |
$0.023B |
0.00 |
Unum Therapeutics (UMRX) |
United States |
$0.021B |
0.00 |
CollPlant Holdings (CLGN) |
Israel |
$0.019B |
0.00 |
VistaGen Therapeutics (VTGN) |
United States |
$0.019B |
0.00 |
Signal Genetics (MGEN) |
United States |
$0.018B |
0.00 |
Pulmatrix (PULM) |
United States |
$0.017B |
0.00 |
AEterna Zentaris (AEZS) |
United States |
$0.017B |
0.00 |
Aytu Bioscience (AYTU) |
United States |
$0.015B |
0.00 |
TOCAGEN INC (TOCA) |
United States |
$0.015B |
0.00 |
IMMURON (IMRN) |
Australia |
$0.014B |
0.00 |
Advaxis (ADXS) |
United States |
$0.013B |
0.00 |
Prana Biotechnology (ATHE) |
Australia |
$0.013B |
0.00 |
MYOS RENS Technology (MYOS) |
United States |
$0.013B |
0.00 |
Titan Pharmaceuticals (TTNP) |
United States |
$0.011B |
0.00 |
TrovaGene (TROV) |
United States |
$0.010B |
0.00 |
Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.010B |
0.00 |
TRACON Pharmaceuticals (TCON) |
United States |
$0.010B |
0.00 |
Cesca Therapeutics (THMO) |
United States |
$0.008B |
0.00 |
Genetic Technologies (GENE) |
Australia |
$0.008B |
0.00 |
Cleveland BioLabs (CBLI) |
United States |
$0.007B |
0.00 |
Benitec Biopharma (BNTC) |
Australia |
$0.007B |
0.00 |
Neuralstem (SNCA) |
United States |
$0.004B |
0.00 |